Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)

NCT02332720 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

413

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir
DRUG: Uprifosbuvir
DRUG: Elbasvir
DRUG: Ruzasvir
DRUG: MK-3682B
DRUG: Ribavirin (RBV)

Sponsor

Merck Sharp & Dohme LLC